Changes in natriuretic peptide and effects of vericiguat in worsening heart failure with reduced ejection fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF)

Back

HFA Premium Access

Changes in natriuretic peptide and effects of vericiguat in worsening heart failure with reduced ejection fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 1

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor J. Ezekowitz (Edmonton, CA)

Event: Heart Failure 2021

Congress Presentation

About the speaker

Professor Justin Ezekowitz

University of Alberta, Edmonton (Canada)

9 presentations

1 follower

9 more presentations in this session

Real world analysis of outcomes of remote pulmonary artery hemodynamic monitoring in overweight and obese patients with heart failure

Speaker: Doctor M. Oberoi (Sioux Falls, US)

Multicenter nationwide study of the prevalence of ATTR-CM in HFpEF in Spain. Intermediate results from national PRACTICA study.

Speaker: Doctor J. Garcia-Pinilla (Malaga, ES)

HDAC6 inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction

Speaker: Mr J. Yang (South San Francisco, US)

Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies

Speaker: Doctor K. Jering (Boston, US)

Access

Abstract

Slides

Initiation of sacubitril/valsartan in patients with renal impairment early after acute decompensated heart failure in the TRANSITION study

Speaker: Professor E. Straburzynska-Migaj (Poznan, PL)

Access the full session

Chronic Heart Failure - Pathophysiology and Mechanisms 1

Speakers: Professor J. Ezekowitz, Doctor M. Oberoi, Doctor J. Garcia-Pinilla, Mr J. Yang, Doctor K. Jering...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

Changes in natriuretic peptide and effects of vericiguat in worsening heart failure with reduced ejection fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF)

About the speaker

Professor Justin Ezekowitz

9 more presentations in this session

Real world analysis of outcomes of remote pulmonary artery hemodynamic monitoring in overweight and obese patients with heart failure

Multicenter nationwide study of the prevalence of ATTR-CM in HFpEF in Spain. Intermediate results from national PRACTICA study.

HDAC6 inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction

Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies

Initiation of sacubitril/valsartan in patients with renal impairment early after acute decompensated heart failure in the TRANSITION study

Access the full session

Chronic Heart Failure - Pathophysiology and Mechanisms 1

About the event

Heart Failure 2021

ESC 365 is supported by